Clinical and Contrast-Enhanced Ultrasound Echography Outcomes in Psoriatic Arthritis Patients after One Year of Continuous Therapy with Anti-TNF Drugs
Figure 2
Median reductions from baseline over time in anti-TNF treated patients of (a) active joint count (AJC); (b) psoriasis area severity index (PASI); (c) health assessment quality (HAQ); (d) dermatology life quality index (DLQI); (e) Visual Analogic Scales (VAS) pain; and (f) visual analogic scales (VAS) itch.
